A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia

BACKGROUND: The FLAIR trial in chronic lymphocytic leukaemia has a randomised, controlled, open-label, confirmatory, platform design. FLAIR was successfully amended to include an emerging promising experimental therapy to expedite its assessment, greatly reducing the time to reach the primary outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Dena R., Hockaday, Anna, Brown, Julia M., Gregory, Walter M., Todd, Susan, Munir, Tahla, Oughton, Jamie B., Dimbleby, Claire, Hillmen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792072/
https://www.ncbi.nlm.nih.gov/pubmed/33419469
http://dx.doi.org/10.1186/s13063-020-04971-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792072/
https://www.ncbi.nlm.nih.gov/pubmed/33419469
http://dx.doi.org/10.1186/s13063-020-04971-2

Ejemplares similares